Skip to main content

Peer Review reports

From: A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Original Submission
12 Jun 2018 Submitted Original manuscript
2 Jul 2018 Author responded Author comments - Roche Kapoor
Resubmission - Version 2
2 Jul 2018 Submitted Manuscript version 2
27 Oct 2018 Author responded Author comments - Roche Kapoor
Resubmission - Version 3
27 Oct 2018 Submitted Manuscript version 3
28 Mar 2019 Reviewed Reviewer Report - Klaus Brasso
10 Apr 2019 Reviewed Reviewer Report - Reviewer 2
5 May 2019 Author responded Author comments - Roche Kapoor
Resubmission - Version 4
5 May 2019 Submitted Manuscript version 4
1 Jun 2019 Author responded Author comments - Roche Kapoor
Resubmission - Version 5
1 Jun 2019 Submitted Manuscript version 5
Publishing
6 Jun 2019 Editorially accepted
13 Jun 2019 Article published 10.1186/s12885-019-5805-z

You can find further information about peer review here.

Back to article page